Avidity BiosciencesRNA
那斯達克 · USD
35.92
-0.79
(-2.15%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Avidity BiosciencesRNA
35.92
-0.79
(-2.15%)
財務數據
損益表
- 0.03
- 0.02
- 0.02
- 0.03
- 0.02
- 0.04
- 0.02
- 0.02
- 0.03
- 0.02
- 11.56
- -19.36
- 3.72
- 21.68
- -22.18
- 61.56
- -42.28
- 14.23
- 27.27
- -47.09
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 1,573 | 2,973 | 2,336 | 2,045 | 3,543 | 2,193 | 2,818 | 2,316 | 2,233 | 2,769 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,573 | 2,973 | 2,336 | 2,045 | 3,543 | 2,193 | 2,818 | 2,316 | 2,233 | 2,769 |
營業費用 | - | 123,963 | 100,469 | 84,671 | 80,730 | 68,936 | 61,443 | 54,950 | 59,829 | 55,994 |
研發費用 | 99,490 | 95,625 | 77,196 | 63,940 | 66,832 | 52,817 | 47,714 | 42,672 | 47,765 | 45,610 |
推銷及管理費用 | 33,600 | 28,338 | 23,273 | 20,731 | 13,898 | 16,119 | 13,729 | 12,278 | 12,064 | 10,384 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -131,517 | -120,990 | -98,133 | -82,626 | -77,187 | -66,743 | -58,625 | -52,634 | -57,596 | -53,225 |
其他收入及費用 | 15,744 | 18,733 | 17,736 | 11,833 | 8,332 | 6,300 | 6,267 | 5,609 | 5,202 | 2,754 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -115,773 | -102,257 | -80,397 | -70,793 | -68,855 | -60,443 | -52,358 | -47,025 | -52,394 | -50,471 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -115,773 | -102,257 | -80,397 | -70,793 | -68,855 | -60,443 | -52,358 | -47,025 | -52,394 | -50,471 |
基本每股稅後盈餘(元) | -0.90 | -0.80 | -0.65 | -0.65 | -0.79 | - | -0.71 | -0.66 | -0.74 | -0.88 |
稀釋每股稅後盈餘(元) | -0.90 | -0.81 | -0.64 | -0.65 | -0.79 | -0.80 | -0.71 | -0.66 | -0.74 | -0.89 |
基本平均股數(千股) | 129232.00 | 128497.00 | 123375.00 | 106928.00 | 87212.00 | - | 74097.00 | 71390.00 | 70433.00 | 57296.00 |
稀釋平均股數(千股) | 129232.00 | 128497.00 | 123375.00 | 106928.00 | 87212.00 | - | 74097.00 | 71390.00 | 70433.00 | 57296.00 |
還原基本每股稅後盈餘(元) | -0.90 | -0.80 | -0.65 | -0.65 | -0.79 | - | -0.71 | -0.66 | -0.74 | -0.88 |
還原稀釋每股稅後盈餘(元) | -0.90 | -0.81 | -0.64 | -0.65 | -0.79 | -0.80 | -0.71 | -0.66 | -0.74 | -0.89 |
還原基本平均股數(千股) | 129,232 | 128,497 | 123,375 | 106,928 | 87,212 | - | 74,097 | 71,390 | 70,433 | 57,296 |
還原稀釋平均股數(千股) | 129,232 | 128,497 | 123,375 | 106,928 | 87,212 | - | 74,097 | 71,390 | 70,433 | 57,296 |
EBITDA(千元) | -120,145 | -108,685 | -86,533 | -74,581 | -71,174 | -63,065 | -54,758 | -49,336 | -54,234 | -50,889 |